Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
For patients with type 2 diabetes and MGUS, poorly controlled diabetes (HbA1c > 7%) may be associated with progression risk (aHR 1.15; 95% confidence interval [CI] 1.01-1.32) to myeloma.”
Title: Association between diabetic control and progression of monoclonal gammopathy of undetermined significance to multiple myeloma
Authors: Lawrence Liu, Byron Sigel, Mei Wang, Nikhil Grandhi, Martin W. Schoen, Kristen M. Sanfilippo, Kenneth R. Carson, Murali Janakiram, Tzeyu L. Michaud, Graham A. Colditz, Theodore S. Thomas, Su-Hsin Chang
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
